The PI3K/Akt/FOXO and NF--κB signaling pathways are constitutively activated in various cancers, including breast cancer, prostate cancer, GC, and pancreatic cancer [35–39], and result in cancer initiation and progression. This evidence concerns the gene NFKB1 and breast cancer.